Kissei Pharmaceutical Statistics

Total Valuation

Kissei Pharmaceutical has a market cap or net worth of JPY 147.46 billion. The enterprise value is 99.88 billion.

Market Cap	147.46B
Enterprise Value	99.88B

Important Dates

The next estimated earnings date is Monday, February 3, 2025.

Earnings Date	Feb 3, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Kissei Pharmaceutical has 42.81 million shares outstanding. The number of shares has decreased by -3.52% in one year.

Current Share Class	n/a
Shares Outstanding	42.81M
Shares Change (YoY)	-3.52%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	3.84%
Owned by Institutions (%)	32.86%
Float	36.10M

Valuation Ratios

The trailing PE ratio is 14.25 and the forward PE ratio is 14.67.

PE Ratio	14.25
Forward PE	14.67
PS Ratio	1.89
PB Ratio	0.69
P/TBV Ratio	0.68
P/FCF Ratio	186.66
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.08, with an EV/FCF ratio of 126.43.

EV / Earnings	9.31
EV / Sales	1.23
EV / EBITDA	12.08
EV / EBIT	26.41
EV / FCF	126.43

Financial Position

The company has a current ratio of 5.50, with a Debt / Equity ratio of 0.01.

Current Ratio	5.50
Quick Ratio	3.98
Debt / Equity	0.01
Debt / EBITDA	0.15
Debt / FCF	1.59
Interest Coverage	210.11

Financial Efficiency

Return on equity (ROE) is 5.11% and return on invested capital (ROIC) is 1.11%.

Return on Equity (ROE)	5.11%
Return on Assets (ROA)	0.96%
Return on Capital (ROIC)	1.11%
Revenue Per Employee	45.57M
Profits Per Employee	6.03M
Employee Count	1,779
Asset Turnover	0.33
Inventory Turnover	1.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+9.02%
50-Day Moving Average	3,669.90
200-Day Moving Average	3,465.70
Relative Strength Index (RSI)	31.27
Average Volume (20 Days)	62,575

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kissei Pharmaceutical had revenue of JPY 81.07 billion and earned 10.73 billion in profits. Earnings per share was 241.69.

Revenue	81.07B
Gross Profit	40.44B
Operating Income	3.78B
Pretax Income	14.10B
Net Income	10.73B
EBITDA	8.27B
EBIT	3.78B
Earnings Per Share (EPS)	241.69

Full Income Statement

Balance Sheet

The company has 49.96 billion in cash and 1.26 billion in debt, giving a net cash position of 48.70 billion or 1,137.74 per share.

Cash & Cash Equivalents	49.96B
Total Debt	1.26B
Net Cash	48.70B
Net Cash Per Share	1,137.74
Equity (Book Value)	220.77B
Book Value Per Share	4,969.03
Working Capital	87.56B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.43 billion and capital expenditures -2.64 billion, giving a free cash flow of 790.00 million.

Operating Cash Flow	3.43B
Capital Expenditures	-2.64B
Free Cash Flow	790.00M
FCF Per Share	18.46

Full Cash Flow Statement

Margins

Gross margin is 49.88%, with operating and profit margins of 4.67% and 13.24%.

Gross Margin	49.88%
Operating Margin	4.67%
Pretax Margin	17.40%
Profit Margin	13.24%
EBITDA Margin	10.20%
EBIT Margin	4.67%
FCF Margin	0.97%

Dividends & Yields

This stock pays an annual dividend of 90.00, which amounts to a dividend yield of 2.61%.

Dividend Per Share	90.00
Dividend Yield	2.61%
Dividend Growth (YoY)	6.17%
Years of Dividend Growth	11
Payout Ratio	34.39%
Buyback Yield	3.52%
Shareholder Yield	6.13%
Earnings Yield	7.02%
FCF Yield	0.54%

Dividend Details

Stock Splits

The last stock split was on March 26, 1996. It was a forward split with a ratio of 1.1.

Last Split Date	Mar 26, 1996
Split Type	Forward
Split Ratio	1.1

Scores

Kissei Pharmaceutical has an Altman Z-Score of 3.69.

Altman Z-Score	3.69
Piotroski F-Score	n/a